International Journal of Hematology

Article	Citations
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	79
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	75
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	44
Carcinocythemia diagnosed on peripheral blood clot sections	38
Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation	31
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	27
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	26
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	24
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	24
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	22
Post-transfusion purpura and adult primary thrombocytopenia	21
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	20
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	20
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	20
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	20
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	19
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	18
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST	18
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	18
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	18
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan	17
Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population	17
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma	17
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	16
Isolated thrombosis after COVID-19 vaccination: case series	16

Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign	16
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	15
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia	14
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study	14
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma	14
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overview	13
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	13
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	13
Ten years’ experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities	13
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	13
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	13
HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA	12
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM	12
Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia	12
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A	12
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	12
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	12
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	11
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma	11
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome	11
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	11
Nodal mature plasmacytoid dendritic cell proliferation mimicking lymphoma in a patient with CALR-mutated myelofibrosis	10
Guest Editorial: what can be done to improve cancer immunotherapies?	10
Evolution and optimization of therapies for acute lymphoblastic leukemia in infants	10
Current and emerging therapeutic strategies in adult T-cell leukemia–lymphoma	10
Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions	10
Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic	10
Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma	10
Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	9
Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution	9
Combined tumor necrosis factor-α (−308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia	9
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023	9
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation	9
Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation	9
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies	9
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation	9
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome	9
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report	9
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic	9
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia	9
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis	9
Effect of delivery mode on postnatal platelet count dynamics in neonates born to mothers with immune thrombocytopenia	9
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia	9
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study	9
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia	9
Multiple myeloma with high-risk cytogenetics and its treatment approach	9
An adult case of refractory autoimmune neutropenia after liver transplantation	9
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds	9
Clinical features of immature leukemias in children	8
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)	8

Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era	8
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	8
Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia	8
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit	8
Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants	8
Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach	8
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia	8
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice	8
Sarcopenia and clinical outcomes in lymphoma and multiple myeloma patients receiving hematopoietic cell transplantation: a systematic review and meta-analysis	8
Auer rods in mature granulocytes in peripheral blood	8
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels	8
Resilient T-cell responses in patients with advanced cancers	8
Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol	8
A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma	8
Correction to: Somatic SETBP1 mutations in myeloid neoplasms	7
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma	7
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial	7
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia	7
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients	7
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	7
The mutual crosstalk between iron and erythropoiesis	7
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system	7
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study	7
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia	7
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation	7
Leukemic-phase mucosa-associated lymphoid tissue lymphoma	7
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis	7
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation	7
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial	7
COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm	7
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia	7
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review	6
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)	6
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia	6
Cardiovascular toxicity from tyrosine kinase inhibitors in chronic myeloid leukemia with severe dilated cardiomyopathy	6
Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia	6
Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms	6
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosis	6
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation	6
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag	6
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia	6
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marke	6
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells	6
FLT3 targeting in the modern era: from clonal selection to combination therapies	6
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases	6
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation	6
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency	6
Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes	6
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	6
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura	6
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors	6
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis	6
Guest editorial: recent progress in pediatric leukemia	5
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB	5
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?	5
Recent advances in AML with mutated NPM1	5
Favorable prognosis of vaccine-associated immune thrombocytopenia in children is correlated with young age at vaccination: Retrospective survey of a nationwide disease registry	5
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	5
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	5
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	5
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients	5
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio	5
Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency	5
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review	5
FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloanti	5
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM	5
Recent advances in understanding the biology of follicular lymphoma	5
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid	5
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes	5
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 4. Mantle cell lymphoma (MCL)	5
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	5
Reply to the Dr. Murphy’s comment	5
Mature T-cell and NK-cell lymphomas: updates on molecular genetic features	5
A case of posttransplant isolated extramedullary relapse of acute lymphoblastic leukemia achieving durable treatment-free remission with blinatumomab and donor lymphocyte infusion	5
Novel immunotherapies in multiple myeloma	5
HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia	5
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center	5
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval	5
Dysregulated hemostasis in acute promyelocytic leukemia	5
Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5

An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma	5
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation	5
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease	5
MYC-rearranged blastic plasmacytoid dendritic cell neoplasm with immunoblastoid features	5
Heme as a differentiation-regulatory transcriptional cofactor	5
Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children	5
VEXAS syndrome	5
Factor XII deficiency: a clinical and molecular genetic study	4
Stem cell regulation and dynamics in myeloid malignancies	4
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	4
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	4
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	4
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma5. Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)	4
Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation	4
Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after fir	4
Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	4
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	4
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation	4
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	4
Bringing mass spectrometry into the care of patients with multiple myeloma	4
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	4
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes	4
A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature review	4
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report	4
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	4
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis o	4
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma—2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associa	4
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	4
Impact of center volume on acute graft versus host disease in allogeneic stem cell transplant recipients	4
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	4
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva	4
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reaction	4
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	4
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency	4
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	4
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution	4
Bosutinib-induced lung injury: a report of two cases and literature review	4
Anakinra for the treatment of adult secondary HLH: a retrospective experience	4
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry	4
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	4
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	4
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	4
Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth	4
Multifocal osteonecrosis after stem cell transplantation	4
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia	4
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	4
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	4
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	4
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	4
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation	4
Successful autologous stem cell transplantation in a case of central nervous system relapse of diffuse large B-cell lymphoma with concurrent polycythemia vera	4
Prognostic value of Glasgow prognostic score in hematological malignancies: a systematic review and meta-analysis	3
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia	3
Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease	3
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancy	3
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients	3
Inclusion of thymic Langerhans cell histiocytosis in the “5 Ts” of the differential diagnosis of anterior mediastinal mass	3
Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood	3
Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children’s Cancer Group	3
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)	3
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02	3
A case of autoimmune factor XIII deficiency due to clearance-accelerating and inhibitory anti-FXIII autoantibodies	3
Persistent neonatal alloimmune thrombocytopenia caused by triple anti-HLA-A11, -B3901, and -Cw7 antibodies	3
FLT3-targeted treatment for acute myeloid leukemia	3
Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy	3
Recent progress in AML with recurrent genetic abnormalities	3
Mitochondrial dynamics as a potential therapeutic target in acute myeloid leukemia	3
Chronic graft-versus-host disease myelitis successfully treated with rituximab	3
Treatment pathways and clinical outcomes in newly diagnosed multiple myeloma outside Europe and North America: The INTEGRATE study	3
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy	3
Paranasal sinus aspergillosis in a patient treated with tirabrutinib	3
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives	3
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin–aldosterone–angiotensin system inhibitors in patients with chronic myelogenous leukemia	3
Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders	3
Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation	3
Histiocytic sarcoma following CAR T-cell therapy: a case report	3
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance	3
Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in Japan	3
Disease response criteria in Langerhans cell histiocytosis: a global view	3
The clinical application of SNP-based next-generation sequencing (SNP-NGS) for evaluation of chimerism and microchimerism after HLA-mismatched stem cell microtransplantation	3
The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage	3
Myeloid sarcoma with plasmacytoid dendritic cell-like proliferation associated with IKZF1, ETV6 and DNMT3A mutations	3
Updated guidelines for chronic active Epstein–Barr virus disease	3
Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant	3
Prediction of major bleeding events in 1381 patients with essential thrombocythemia	3
Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin	3
Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma	3
Quality of life of children and adolescents with hemophilia receiving low-dose prophylactic treatment	3
Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells	3
First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants	3
Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes	3
Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis	3
Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria	3
Relationship between hemoglobinopathies and male infertility: a scoping review	3
A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies	3